Related Experiment Video
Updated: May 12, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Fatal anaphylactoid reaction associated with heparin-induced thrombocytopenia
Atul Singla1, Mohammad R Amini, Martin A Alpert
1Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, Missouri 65212, USA.
Abstract:
Acute systemic (anaphylaxis and anaphylactoid) reactions have been well described in patients with heparin-induced thrombocytopenia (HIT). Both necrotizing and non-necrotizing skin lesions at heparin injection sites have been reported and may occur in 10-20% of patients with HIT. We report herein a patient treated with subcutaneous enoxaparin sodium who developed non-necrotizing erythematous skin lesions at enoxaparin sodium injection sites. A subsequent intravenous bolus of unfractionated heparin produced a fatal anaphylactoid reaction. This suggests that caution should be exercised in the administration of intravenous heparin to patients with non-necrotizing erythematous skin lesions at prior heparin injection sites.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hypersensitivity Reactions: Cytolytic Reactions
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Hypersensitivity Reactions: Immune-Complex Reactions
Allergic Reactions
